United States· US:71655-578_58f2d4af-2a78-c5f5-e063-6294a90a36bb
Ebanga
A ansuvimab product containing ansuvimab, registered in United States by Emergent BioDefense Operations Lansing LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ANSUVIMAB
- Manufacturer
- Emergent BioDefense Operations Lansing LLC
- Country
- United States (US)
- ATC code
- J06BD04
- ATC class
- Ansuvimab
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 3
- ndc1171655-578-03
- ndc1171655-578-04
- ndc1171655-578-08
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J06BD04
Ansuvimab, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6c3f2f8-ddc6-461f-b188-aabb73fafad8 GET /v1/drugs/b6c3f2f8-ddc6-461f-b188-aabb73fafad8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "400",
"substance": "ANSUVIMAB",
"productndc": "71655-578",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/8mL",
"application_number": "BLA761172",
"marketing_category": "BLA"
}See everything about ansuvimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.